Literature DB >> 19208740

p53 mutant human glioma cells are sensitive to UV-C-induced apoptosis due to impaired cyclobutane pyrimidine dimer removal.

Luis F Z Batista1, Wynand P Roos, Bernd Kaina, Carlos F M Menck.   

Abstract

The p53 protein is a key regulator of cell responses to DNA damage, and it has been shown that it sensitizes glioma cells to the alkylating agent temozolomide by up-regulating the extrinsic apoptotic pathway, whereas it increases the resistance to chloroethylating agents, such as ACNU and BCNU, probably by enhancing the efficiency of DNA repair. However, because these agents induce a wide variety of distinct DNA lesions, the direct importance of DNA repair is hard to access. Here, it is shown that the induction of photoproducts by UV light (UV-C) significantly induces apoptosis in a p53-mutated glioma background. This is caused by a reduced level of photoproduct repair, resulting in the persistence of DNA lesions in p53-mutated glioma cells. UV-C-induced apoptosis in p53 mutant glioma cells is preceded by strong transcription and replication inhibition due to blockage by unrepaired photolesions. Moreover, the results indicate that UV-C-induced apoptosis of p53 mutant glioma cells is executed through the intrinsic apoptotic pathway, with Bcl-2 degradation and sustained Bax and Bak up-regulation. Collectively, the data indicate that unrepaired DNA lesions induce apoptosis in p53 mutant gliomas despite the resistance of these gliomas to temozolomide, suggesting that efficiency of treatment of p53 mutant gliomas might be higher with agents that induce the formation of DNA lesions whose global genomic repair is dependent on p53.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19208740     DOI: 10.1158/1541-7786.MCR-08-0428

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  11 in total

1.  Pharmacodynamic modeling of cell cycle and apoptotic effects of gemcitabine on pancreatic adenocarcinoma cells.

Authors:  Salaheldin S Hamed; Robert M Straubinger; William J Jusko
Journal:  Cancer Chemother Pharmacol       Date:  2013-07-09       Impact factor: 3.333

Review 2.  Autophagy and genomic integrity.

Authors:  A T Vessoni; E C Filippi-Chiela; C Fm Menck; G Lenz
Journal:  Cell Death Differ       Date:  2013-08-09       Impact factor: 15.828

3.  Enhancement of temozolomide-induced apoptosis by valproic acid in human glioma cell lines through redox regulation.

Authors:  Ching-Hsein Chen; Yu-Jia Chang; Maurice S B Ku; King-Thom Chung; Jen-Tsung Yang
Journal:  J Mol Med (Berl)       Date:  2011-02-23       Impact factor: 4.599

4.  Pseudoprogression in patients with malignant gliomas treated with concurrent temozolomide and radiotherapy: potential role of p53.

Authors:  Hyun-Cheol Kang; Chae-Yong Kim; Jung Ho Han; Ghee Young Choe; Jae Hyoung Kim; Jee Hyun Kim; In Ah Kim
Journal:  J Neurooncol       Date:  2010-07-15       Impact factor: 4.130

5.  Growth inhibitory effects of the Diruthenium-Ibuprofen compound, [Ru2Cl(Ibp) 4], in human glioma cells in vitro and in the rat C6 orthotopic glioma in vivo.

Authors:  Marcel Benadiba; Iguatinã de M Costa; Rodrigo L S R Santos; Fernanda Oliveira Serachi; Denise de Oliveira Silva; Alison Colquhoun
Journal:  J Biol Inorg Chem       Date:  2014-05-14       Impact factor: 3.358

6.  Investigation of the peak action wavelength of light-activated gene transduction.

Authors:  M Myakishev-Rempel; J Kuper; B Mintz; S Hutchinson; J Voris; K Zavislan; S Offley; F B Nardia; Z Yaseen; T Yen; J M Zavislan; M D Maloney; E M Schwarz
Journal:  Gene Ther       Date:  2011-04-14       Impact factor: 5.250

Review 7.  Functions of MDMX in the modulation of the p53-response.

Authors:  Kristiaan Lenos; Aart G Jochemsen
Journal:  J Biomed Biotechnol       Date:  2011-03-22

8.  Lipocalin 2 Enhances Migration and Resistance against Cisplatin in Endometrial Carcinoma Cells.

Authors:  Tsutomu Miyamoto; Hiroyasu Kashima; Yasushi Yamada; Hisanori Kobara; Ryoichi Asaka; Hirofumi Ando; Shotaro Higuchi; Koichi Ida; David Hamisi Mvunta; Tanri Shiozawa
Journal:  PLoS One       Date:  2016-05-11       Impact factor: 3.240

9.  Combination of lentivirus-mediated silencing of PPM1D and temozolomide chemotherapy eradicates malignant glioma through cell apoptosis and cell cycle arrest.

Authors:  Peng Wang; Jing-An Ye; Chong-Xian Hou; Dong Zhou; Sheng-Quan Zhan
Journal:  Oncol Rep       Date:  2016-09-14       Impact factor: 3.906

10.  BmK CT enhances the sensitivity of temozolomide-induced apoptosis of malignant glioma U251 cells in vitro through blocking the AKT signaling pathway.

Authors:  Jun Du; Ruijie Wang; Litian Yin; Yuejun Fu; Yuqing Cai; Zhiyun Zhang; Aihua Liang
Journal:  Oncol Lett       Date:  2017-11-24       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.